title: Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
authors.affiliation: Centre de Résonance Magnétique Biologique et Médicale, Faculté de Médicine, Marseille, France. patrick.cozzone@medecine.univ-mrs.fr
authors.forename: S
authors.initials: S
authors.lastname: Guis
authors.forename: D
authors.initials: D
authors.lastname: Bendahan
authors.forename: G
authors.initials: G
authors.lastname: Kozak-Ribbens
authors.forename: D
authors.initials: D
authors.lastname: Figarella-Branger
authors.forename: J P
authors.initials: JP
authors.lastname: Mattei
authors.forename: J F
authors.initials: JF
authors.lastname: Pellissier
authors.forename: S
authors.initials: S
authors.lastname: Treffouret
authors.forename: V
authors.initials: V
authors.lastname: Bernard
authors.forename: A
authors.initials: A
authors.lastname: Lando
authors.forename: P J
authors.initials: PJ
authors.lastname: Cozzone
mesh_terms: D000069059:Atorvastatin; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D004198:Disease Susceptibility; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008305:Malignant Hyperthermia / Q000175:diagnosis*; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced*; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D002800:Cholinesterase Inhibitors; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin